These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 28533233

  • 1. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.
    Johnson JR, Porter S, Thuras P, Castanheira M.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533233
    [Abstract] [Full Text] [Related]

  • 2. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
    Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.
    Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
    [Abstract] [Full Text] [Related]

  • 3. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M, Clabots C, Porter SB, Thuras P, Johnson JR.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4638-45. PubMed ID: 27185805
    [Abstract] [Full Text] [Related]

  • 4. The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).
    Johnson JR, Porter S, Thuras P, Castanheira M.
    Open Forum Infect Dis; 2017 Aug; 4(2):ofx089. PubMed ID: 28638846
    [Abstract] [Full Text] [Related]

  • 5. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M.
    Clin Infect Dis; 2010 Aug 01; 51(3):286-94. PubMed ID: 20572763
    [Abstract] [Full Text] [Related]

  • 6. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.
    Antimicrob Agents Chemother; 2015 Aug 01; 59(8):4471-80. PubMed ID: 25987621
    [Abstract] [Full Text] [Related]

  • 7. Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD, Thuras P, Johnson JR.
    PLoS One; 2018 Aug 01; 13(7):e0200442. PubMed ID: 29990385
    [Abstract] [Full Text] [Related]

  • 8. Emergence of Antibiotic Resistance-Associated Clones Among Escherichia coli Recovered From Newborns With Early-Onset Sepsis and Meningitis in the United States, 2008-2009.
    Weissman SJ, Hansen NI, Zaterka-Baxter K, Higgins RD, Stoll BJ.
    J Pediatric Infect Dis Soc; 2016 Sep 01; 5(3):269-76. PubMed ID: 26407251
    [Abstract] [Full Text] [Related]

  • 9. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
    Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D.
    BMC Microbiol; 2017 Mar 27; 17(1):71. PubMed ID: 28347271
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.
    Miles-Jay A, Weissman SJ, Adler AL, Tchesnokova V, Sokurenko EV, Baseman JG, Zerr DM.
    Clin Infect Dis; 2018 Jan 18; 66(3):411-419. PubMed ID: 29020219
    [Abstract] [Full Text] [Related]

  • 11. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV.
    mBio; 2013 Dec 17; 4(6):e00377-13. PubMed ID: 24345742
    [Abstract] [Full Text] [Related]

  • 12. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM, Hassuna NA.
    Microb Drug Resist; 2017 Mar 17; 23(2):224-229. PubMed ID: 27214282
    [Abstract] [Full Text] [Related]

  • 13. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O.
    Eur J Clin Microbiol Infect Dis; 2017 Oct 17; 36(10):1859-1866. PubMed ID: 28550370
    [Abstract] [Full Text] [Related]

  • 14. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD, Thuras PD, Johnson JR.
    Diagn Microbiol Infect Dis; 2020 Jul 17; 97(3):115034. PubMed ID: 32331800
    [Abstract] [Full Text] [Related]

  • 15. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.
    Olesen B, Frimodt-Møller J, Leihof RF, Struve C, Johnston B, Hansen DS, Scheutz F, Krogfelt KA, Kuskowski MA, Clabots C, Johnson JR.
    Antimicrob Agents Chemother; 2014 Nov 17; 58(11):6886-95. PubMed ID: 25199783
    [Abstract] [Full Text] [Related]

  • 16. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.
    Banerjee R, Johnson JR.
    Antimicrob Agents Chemother; 2014 Sep 17; 58(9):4997-5004. PubMed ID: 24867985
    [Abstract] [Full Text] [Related]

  • 17. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM, Porter S, Kuskowski MA, Johnston B, Clabots C, Kline S, Ferrieri P, Johnson JR.
    Antimicrob Agents Chemother; 2015 Sep 17; 59(9):5331-9. PubMed ID: 26100703
    [Abstract] [Full Text] [Related]

  • 18. Occurrence of ESBL-Producing Escherichia coli ST131, Including the H30-Rx and C1-M27 Subclones, Among Urban Seagulls from the United Kingdom.
    Zendri F, Maciuca IE, Moon S, Jones PH, Wattret A, Jenkins R, Baxter A, Timofte D.
    Microb Drug Resist; 2020 Jun 17; 26(6):697-708. PubMed ID: 32519936
    [Abstract] [Full Text] [Related]

  • 19. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC, Oprea M, Neacşu G, Gîlcă R, Popa MI, Usein CR.
    Roum Arch Microbiol Immunol; 2015 Jun 17; 74(3-4):73-8. PubMed ID: 27328520
    [Abstract] [Full Text] [Related]

  • 20. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI, Siarkou VI, Batzias G, Kaltsogianni F, Sianou E, Tzavaras I, Koutinas A, Saridomichelakis MN, Sofianou D, Tzelepi E, Miriagou V.
    J Antimicrob Chemother; 2014 Aug 17; 69(8):2076-80. PubMed ID: 24722836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.